SecBot SecBot
4258-K ·Filed Jul 23, 2026

THRM

Gentherm Inc
BULLISH
Impact 6/10
Horizonweeks Processed3mo ago SEC0001193125-26-313208
Actionable Insight ▲ Bullish

The combination of record revenue, raised guidance, and a $400M buyback authorization (36% of market cap) is a strong bullish signal. However, the sharp decline in GAAP operating income and operating cash flow due to restructuring/M&A costs warrants monitoring for normalization in H2. The Modine deal closing in early Q4 is the next major catalyst, watch for S-4 effectiveness and shareholder vote.

DirectionBullish
Confidencehigh
Horizonweeks

How the stock moved after the report

⚠ Clustered BULLISH VIEWSTOCK BELOW ENTRY AT T+60
Entry
$45.61
T+0 close · Jul 23, 2026 · via day close
Latest settled
−34.64%
T+60 · $29.81
Vs SPY
−39.19%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · Jul 23 $45.61entry
  2. T+1 · 4mo ago −6.40%α −6.50% · $42.69
  3. T+5 · 4mo ago −7.21%α −7.69% · $42.32
  4. T+20 · 3mo ago −10.81%α −14.12% · $40.68
  5. T+60 · 5w ago −34.64%α −39.19% · $29.81
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Gentherm reported record Q2 2026 revenue of $416.2M, up 11.0% YoY (9.5% ex-FX), and raised full-year 2026 guidance for revenue, Adjusted EBITDA, and free cash flow. The Board also authorized a new $400M stock repurchase program, replacing the prior $150M program. The company completed the acquisition of Innovative Medical Equipment, LLC and confirmed the Modine Performance Technologies combination remains on track for early Q4 2026. However, GAAP operating income declined sharply to $10.7M from $24.0M due to elevated restructuring and M&A expenses, and operating cash flow fell to $2.3M from $31.7M, tempering the headline revenue beat.

Key Facts

  • Record quarterly product revenue of $416.2M, up 11.0% YoY (9.5% ex-FX)
  • Full-year 2026 guidance raised: revenue to $1.55B-$1.65B (from $1.5B-$1.6B), Adjusted EBITDA to $185M-$200M (from $175M-$195M)
  • Board authorized new $400M stock repurchase program (3-year term), replacing prior $150M program with $110.1M remaining
  • Adjusted diluted EPS of $0.75 vs $0.54 YoY; GAAP diluted EPS $0.14 vs $0.02 YoY
  • GAAP operating income fell to $10.7M from $24.0M; operating cash flow dropped to $2.3M from $31.7M
  • Acquired Innovative Medical Equipment, LLC (ThermaZone device); Modine Performance Technologies deal on track for early Q4 2026
  • Net leverage of ~0.3x; liquidity of $502.3M; cash and equivalents $213.2M

Financial Impact

Record quarterly revenue of $416.2M (+11% YoY); Adjusted EBITDA $48.8M (11.7% margin); GAAP net income $4.4M vs $0.5M; raised FY guidance midpoint by $75M revenue and $7.5M EBITDA

revenueadjustedEbitdaadjustedEpsoperatingCashFlowshareRepurchaseAuthorization

Risk Factors

  • GAAP operating income declined 55% YoY due to $12.9M M&A and $6.0M restructuring costs
  • Operating cash flow fell to $2.3M from $31.7M; free cash flow was negative $11.9M YTD
  • Modine Performance Technologies deal integration risk and potential shareholder approval delays
  • Automotive production in relevant markets expected to decline at low single-digit rate in 2026
  • Gross margin contracted 70bps YoY to 23.2% due to higher material costs and warranty accruals

Market Snapshot

Exchange
Nasdaq
Sector
Motor Vehicle Parts & Accessories
Analyst Consensus
71% bullish (14 analysts)

Investment Themes

Industrials & Manufacturing

Documents Analyzed

This report is based on 9 SEC documents filed with EDGAR.

DocumentAccession Number
425 Filing (THRM), Batch item 10001193125-26-313208
Document: 0001193125-26-313208-index-headers.html0001193125-26-313204
Document: 0001193125-26-313208-index.html0001193125-26-313208
Document: 0001193125-26-313208.txt0001193125-26-313208
8-K Filing (THRM), Batch item 50001193125-26-313204
Document: thrm-20260723.htm0001193125-26-313208
Document: 0001193125-26-313204-index-headers.html0001193125-26-313208
Document: 0001193125-26-313204-index.html0001193125-26-313208
Document: 0001193125-26-313204.txt0001193125-26-313208

Track record

25 reports on THRM

Performance horizon

2 of 6 bullish or bearish reports moved the stock their way by T+20. Best: +20.29% at T+60 after the Apr 23, 2026 report. 5 of 8 went positive at some point.

Filters
  1. Oct 26, 202621d ago Insider Cluster Bullish 4/10 Entry $31.82 Now $28.53 −10.34% settles Nov 24
  2. Oct 22, 202625d ago 8-K Bearish 6/10 Entry $26.15 Now $28.53 −9.10% settles Nov 19
  3. Oct 9, 20265w ago 8-K/A Neutral 5/10 Entry $30.92 to $30.38 Now $28.53 −7.73% ▼ −1.75% +1.52% vs SPY
  4. Oct 6, 20265w ago 3 Neutral 2/10 Entry $30.38 to $31.11 Now $28.53 −6.09% ▲ +2.40% +3.74% vs SPY
  5. Oct 1, 20266w ago 8-K Neutral 6/10 Entry $31.30 to $30.95 Now $28.53 −8.85% ▼ −1.12% +0.69% vs SPY
  6. Oct 1, 20266w ago Press Release Neutral 5/10 Entry $31.30 to $30.95 Now $28.53 −8.85% ▼ −1.12% +0.69% vs SPY
  7. Sep 17, 20268w ago Press Release Neutral 5/10 Entry $36.35 to $29.04 Now $28.53 −21.51% ▼ −20.11% −20.31% vs SPY
  8. Sep 11, 20269w ago 8-K Bullish 6/10 Entry $38.85 to $29.68 Now $28.53 −26.56% ▼ −23.60% −25.47% vs SPY
  9. Sep 10, 20269w ago Press Release Bullish 7/10 Entry $38.33 to $29.93 Now $28.53 −25.57% ▼ −21.91% −24.04% vs SPY
  10. Aug 13, 202613w ago EFFECT Neutral 3/10 Entry $43.07 to $38.85 Now $28.53 −33.76% ▼ −9.80% −8.05% vs SPY
Showing 10 of 25

US Market Status

Market Closed · Opens in 6h 23m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Jul 23, 2026